Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit! If you are interested in the 2024 event, please get in touch at info@hansonwade.com
Download the Adenosine-Pathway Targeted Cancer Immunotherapy Summit Full Event Guide
Harness cutting-edge insights across 3 days of exclusive content from industry heavyweights including AstraZeneca, Harvard Medical School, Phanes Pharmaceuticals, iTeos Pharmaceuticals and more to maximize the commercial opportunity of the adenosine-pathway as a second-generation immuno-oncology target.
Trouble downloading the brochure? Request a copy here
Here's a Sneak Peak of Topics Discussed:
Adenosine’s Role in IO – How Clinical Progress in Adenosine is Shaping the Future of Immunotherapy
Clinical Development Challenges & Rational Strategies For More a Confident Approach to Clinical Trials
Preclinical Modeling In Vivo, In Vitro & Ex Vivo for Confident Clinical Translation of Adenosine Targeted Therapeutics
CD73/CD39 Understanding Biological Principles & Concepts to Enable Fast Development
Exploring Adenosine Receptor Biology & Taking Advantage of its Strengths